Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Orphenadrine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for orphenadrine citrate and what is the scope of orphenadrine citrate freedom to operate?

Orphenadrine citrate
is the generic ingredient in two branded drugs marketed by Watson Labs, Sandoz, Tedor Pharma Inc, Teligent, Medicis, Invagen Pharms, West-ward Pharms Int, Ascot, Impax Pharms, Akorn, Gavis Pharms, and Sagent Pharms, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for orphenadrine citrate. Thirty suppliers are listed for this compound.

Summary for Generic Name: orphenadrine citrate

Drug Master File Entries: see list9
Suppliers / Packagers: see list30
Clinical Trials: see list228
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:orphenadrine citrate at DailyMed

Pharmacology for Ingredient: orphenadrine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tedor Pharma Inc
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040249-001Jan 29, 1999ABRXNoNo► Subscribe► Subscribe
Impax Pharms
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL040368-001Jun 23, 2000ABRXNoNo► Subscribe► Subscribe
orphenadrine citrate
INJECTABLE;INJECTION013055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
orphenadrine citrate
INJECTABLE;INJECTION084779-001Mar 15, 1982APRXNoNo► Subscribe► Subscribe
orphenadrine citrate
TABLET, EXTENDED RELEASE;ORAL088067-001Apr 6, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus